Camphor Oil and Toenail Fungus: The Vicks Study Explained
The Vicks toenail study tested a finished ointment, Vicks VapoRub, on 18 people for 48 weeks. Five reached both mycological and clinical clearance. It was a small pilot study with no camphor-oil arm, so it cannot tell you what camphor essential oil does on a nail. Here is what it measured, what it did not, and why that matters.
Camphor Essential Oil
Our own Camphor Essential Oil, in sizes from 0.5 oz to bulk.
From $8.69
Shop Now →Toenail fungus is one of those subjects where a single small paper has traveled far beyond what it can bear. The study is real, published in a respected family medicine journal, and cited constantly. The retelling, though, often drops the denominator, the design and the product. We think the careful version is more useful than the viral one, and it leads to a firm conclusion: this is a question for a clinician, and our oil is not part of the answer. For the wider picture of camphor and skin, see camphor oil on skin: evidence, irritation risk and limits.
What the study was
The paper is Derby and colleagues, a clinical case series of an over-the-counter mentholated ointment for onychomycosis, published in the Journal of the American Board of Family Medicine in January 2011 (volume 24, issue 1, pages 69 to 74). Its abstract calls it a pilot study. Eighteen participants were recruited to use Vicks VapoRub. They were followed at 4, 8, 12, 24, 36 and 48 weeks, with digital photographs taken at the initial and follow-up visits. The primary outcomes were mycological cure at 48 weeks and clinical cure, judged both subjectively and by measuring the affected nail area on photographs. Patient satisfaction was a secondary outcome.
The results as reported: 15 of 18 participants (83 percent) showed a positive effect. Five (27.8 percent) had both mycological and clinical cure at 48 weeks, ten (55.6 percent) had partial clearance, and three (16.7 percent) had no change. All 18 rated their satisfaction with nail appearance at the end as satisfied (9) or very satisfied (9). The authors concluded that Vicks VapoRub seems to have a positive clinical effect on onychomycosis.
Notice the structure of those numbers. "83 percent showed an effect" folds partial clearance into the headline. The figure for full mycological and clinical clearance is 5 of 18. Both are accurate, and they tell very different stories. When someone quotes only the first, you are hearing a more optimistic version than the paper's own abstract supports.
What the study was not
| Question | Answer from the abstract and reasoning |
|---|---|
| Was camphor oil tested? | No. The product tested was a finished ointment |
| Which ingredient, if any, did the work? | Cannot be told from a single-product case series |
| Was there a placebo or comparison group? | The paper is titled a clinical case series, and no comparison arm is described in the abstract |
| How many people? | 18, which the abstract calls a pilot |
| Does it show the oil in our shop would behave the same? | No |
The product matters. A listing for Vicks VapoRub on a drug-label aggregator shows active ingredients of camphor 4.8 percent, eucalyptus oil 1.2 percent and menthol 2.6 percent, in an ointment base. That is a mixture, in a vehicle, at fixed strengths. Even if the ointment had an effect, no one can say whether camphor, menthol, eucalyptus oil, the base or the daily act of applying and massaging it was responsible. Reading the result as "camphor works on toenail fungus" skips a step that the data do not allow.
It is also a measurement problem. Photographs of nail area and subjective clinical judgment are softer than the culture-confirmed, blinded endpoints used in larger trials. We are not criticizing the investigators, who called their work a pilot. We are saying that a pilot is a reason to run a better study, not a basis for a household protocol.
What later reviews conclude
A 2025 narrative review in PeerJ by Valido and colleagues searched PubMed, Web of Science and Embase for human use and complications of Vicks VapoRub and included 37 of 220 studies. For onychomycosis it found two studies and called the evidence limited and inconclusive. It also catalogued complications, including camphor toxicity (5 case reports), lipid pneumonia (11), ocular injury (5) and dermatological conditions (3), with many of the severe outcomes linked to misuse. The authors advise against heating the product, ingesting it, or applying it in the nose, mouth or eyes.
A 2023 analysis in Cureus on camphor- and menthol-containing agents found 15 health-related articles among 103 results and described pain, itch and upper respiratory symptoms as the areas of potential effectiveness. Onychomycosis is not in that summary. Taken together, the later literature does not turn a pilot into an established use.
Why a bottle of essential oil is a different proposition
Three differences are worth spelling out, and they are reasoning from the facts above, not test results.
- Concentration. A finished ointment holds camphor at a fixed single-digit percentage. Camphor essential oil is the whole bottle. FDA's over-the-counter monograph M017 lists camphor in two ranges, 0.1 to 3 percent and above 3 percent up to 11 percent, both for finished products. Our oil is far above either, and nothing in the Derby paper licenses undiluted oil on a nail.
- Vehicle. An ointment base holds the actives against the skin and nail. Dilute oil in a carrier behaves differently, and neat oil differently again. The study cannot speak to any of them.
- Skin around the nail. M017 defines camphor above 3 percent as a counterirritant and its labels say to not apply to wounds or damaged skin. Skin around a nail can be cracked or inflamed, and that is damaged skin by the label's own wording.
The same camphor-and-VapoRub literature includes a note of caution for contact allergy: the AAAAI "Ask the Expert" page describes case reports of allergic contact dermatitis to camphor in sunscreen and ear drops, plus a VapoRub report that may have involved other essential oils.
What we would do, and what we would not
If you think you have toenail fungus, our advice is to get the nail looked at. A nail that looks fungal may not be, and only a clinician can say what is going on with yours. Anyone with diabetes, poor circulation, a weakened immune system or a nail that is painful, draining or changing quickly should see a doctor or podiatrist rather than experiment.
We would not put camphor essential oil on a nail as a home attempt, and we would not use the Vicks paper to justify doing so. If you want to explore camphor foot products for their scent and cooling feel, our DIY page on a camphor foot soak and balm is built around dilution arithmetic and a podiatry caution rather than any claim about nails. For a head-to-head on the other oil people raise in this context, see camphor vs tea tree oil, and for what is in the commercial rubs themselves, camphor rubs compared.
For children, the answer is firmer still. The Healio pharmacy column by Edward Bell, PharmD, cites AAP Committee on Drugs advice from 1994 that camphor not be used in children.
What we sell, said once
We sell one product, Camphor Essential Oil, Cinnamomum camphora, described on our pages as the white fraction of the wood distillate, bottled undiluted in dark amber glass with a tight closure, in sizes from 0.5 oz to 400 lb. It is an aromatic and cosmetic material, not a drug, and not offered for any nail or skin condition. Our shop page lists the sizes, and our Inside the Still page explains what we ask for on every lot. The posted certificate of analysis (batch CMPQGACCCNC003A) lists physical constants such as specific gravity 0.878 and refractive index 1.467, not a GC/MS profile or a safrole figure.
Questions we would expect
Does the Vicks study prove camphor works on toenail fungus?
No. It was an 18-person pilot of a finished mixture. Five participants reached mycological and clinical clearance at 48 weeks, and a later review called the evidence limited and inconclusive.
Is VapoRub on nails safe to try?
Ask a clinician. The 2025 review documents complications from misuse, and anyone with diabetes or circulation problems should not experiment with foot products.
Can I use camphor essential oil the same way?
We would not. The study did not test essential oil, and undiluted oil is far stronger than any figure on a drug label.
This page was written from published sources and has not been reviewed by a medical professional.
Camphor Essential Oil
Camphor Essential Oil from our own shop, in sizes from 0.5 oz to bulk.
From $8.69
Shop Now →Sources & Further Reading
- Derby R et al. Over-the-counter mentholated ointment and onychomycosis: a clinical case series. J Am Board Fam Med 2011
- Valido A et al. There's the Rub: benefits and complications of Vicks VapoRub use. PeerJ 2025
- Hoang D, Wong A, Olympia RP. Current state of research on camphor- and menthol-containing agents. Cureus 2023
- Drug label listing: Vicks VapoRub active ingredients
- FDA OTC Monograph M017: External Analgesic Drug Products for OTC Human Use
- AAAAI Ask the Expert: Camphor and menthol allergy
- Healio: Camphor use entails unique safety concerns